Interventional Cardiology Review

Interventional Cardiology Review (ICR) is a journal published three times a year, designed to help doctors keep up with important developments and insights in the field of interventional cardiology. ICR offers detailed reviews on various relevant topics to aid physicians in enhancing their knowledge and improving their skills for everyday clinical practice.

International, Trade/B2B

English

Journal

Outlet metrics

Domain Authority

Ranking

Global

#609813

United States

#540087

Health/Medicine

#3554

Traffic sources

Monthly visitors

Articles

Saman Nematollahi

1 month ago | radcliffecardiology.com | Gurleen Kaur |Saman Nematollahi |Thomas Das

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media. Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.
Pablo Moriña Vazquez

2 months ago | radcliffecardiology.com | Weijian Huang |Pablo Vazquez

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media. Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.
THT 2025: Supporting REBALANCE-HF: GSN Ablation Reduces Estimated Stressed Blood Volume in HFpEF

2 months ago | radcliffecardiology.com | Pablo Vazquez |Marat Fudim |Barry A. Borlaug |Alexander Sullivan

THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.
THT 2025: FASTR: Fluid Management of Acute Decompensated Heart Failure with Reprieve Decongestion Management System

2 months ago | radcliffecardiology.com | James E. Udelson |Gregg W. Stone |Nisha Bansal |Antonio Ceriello

THT Conference 2025 - Positive safety and efficacy outcomes were found of the Reprieve decongestion management system (DMS; Reprieve Cardiovascular, Inc) for the treatment of acute decompensated heart failure (ADHF). Urinary sodium excretion was seen to be significantly higher in the Reprieve DMS arm than in the control arm, and there were fewer UTI infections in ADHF patients receiving the Reprieve DMS.
THT 25: RELIEVE-HF: Predictors of Outcomes After Interatrial Shunt in HFrEF and HFpEF

2 months ago | radcliffecardiology.com | Gregg W. Stone |Nisha Bansal |Antonio Ceriello |David C. Wheeler

Video Published: Views: 14 Likes: 0 Average (ratings) THT Conference 2025 - Outcomes after heart failure patients were treated with an interatrial shunt show heart failure with reduced ejection fraction (HFrEF) patients had further benefit compared to heart failure with preserved ejection fraction (HFpEF) patients.
Time-Restricted Eating: Clinical Insights for Metabolic Syndrome Management

2 months ago | radcliffecardiology.com | Pam R Taub |David Power

Time-restricted eating in comparison to standard of care for patients with metabolic syndrome caused a reduction in hemoglobin A1C, LDL cholesterol, and body fat. What do these benefits suggest for the future of metabolic syndrome management?
Naureen Khan | Radcliffe Cardiology

2 months ago | radcliffecardiology.com | László Göbölös |Yosef Manla |Naureen Khan

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media. Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.
Spotlight on Uncontrolled Hypertension: Assessing the Shift Towards Personalised Medicine – Part 1

Jan 15, 2025 | radcliffecardiology.com | Jordana B. Cohen |Kazem Rahimi

Faculty: Overview The programme provides an in-depth exploration of the latest strategies for managing uncontrolled hypertension, guided by recent recommendation from the ESC, ESH and KDIGO. It will examine different approaches to blood pressure control and evaluate the impact of guidance summaries such as the recent MASTERplan document, published in 2024.
Challenging Cases in Cardio-Oncology

Jan 8, 2025 | radcliffecardiology.com | Joe Carver |Dan Lenihan

Faculty: Overview Join Dr Joe Carver (University of Pennsylvania, US) and Dr Dan Lenihan (Saint Francis Healthcare System, US) as they discuss complex clinical scenarios at the intersection of heart disease and cancer treatment. This session will provide essential insights into the latest approaches to managing cardiac complications in cancer patients, including novel therapies, diagnostic challenges and risk mitigation strategies.
Ep 123: Redefining Cardiology Careers: Flexibility, Equity and Professional Advancement with Dr Sharonne Hayes

Dec 6, 2024 | radcliffecardiology.com | Ankur Kalra

In this compelling episode of Parallax, host Ankur Kalra sits down with Dr Sharonne Hayes, a trailblazing Professor of Cardiovascular Medicine and the vice chair for academic advancement and faculty development at Mayo Clinic. Together, they explore the critical intersections of career flexibility, diversity, and inclusion in modern medicine.